Vol 4 (April 2019): AME Medical Journal

Editorial Commentary

Abiraterone plus prednisone or enzalutamide in patients with metastatic castration-resistant prostate cancer: is a question of quality?

Daniele Lavacchi, Enrico Mini, Giandomenico Roviello

AME Medical Journal

2019;

4:

24

(23 April 2019)

PDF Full Text (3824) COI Form Open Access

Medical Education Column

The Science and Art of Medicine at McGill University

David H. Eidelman

AME Medical Journal

2019;

4:

23

(23 April 2019)

PDF Full Text (2688) COI Form Open Access

Editorial Commentary

Prostatectomy versus watchful waiting in patients with localized prostate cancer: the survival benefit can be spotted in the long run

Luca Afferi, Stefania Zamboni, Philipp Baumeister, Livio Mordasini, Agostino Mattei, Marco Moschini

AME Medical Journal

2019;

4:

22

(18 April 2019)

PDF Full Text (2265) COI Form Open Access

Editorial Commentary

Systemic and intestinal chronic inflammation, diet and cancer: an unbreakable bond

Cristiano Capurso

AME Medical Journal

2019;

4:

21

(16 April 2019)

PDF Full Text (1303) COI Form Open Access

Medical Writing Corner

Lost in translation

Jeremy Dean Chapnick

AME Medical Journal

2019;

4:

20

(08 April 2019)

PDF Full Text (3663) COI Form Open Access